Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection

Background. In the Strategic Timing of Antiretroviral Treatment (START) study, immediate combination antiretroviral therapy (cART) initiation reduced cancer risk by 64%. We hypothesized that risk reduction was higher for infection-related cancer and determined by differences in CD4 cell counts and h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Borges, Álvaro H., Neuhaus, Jacqueline, Babiker, Abdel G., Henry, Keith, Jain, Mamta K., Palfreeman, Adrian, Mugyenyi, Peter, Domingo, Pere, Hoffmann, Christian, Read, Tim R. H., Pujari, Sanjay, Meulbroek, Michael, Johnson, Margaret, Wilkin, Timothy, Mitsuyasu, Ronald
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
HIV/AIDS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5146718/
https://ncbi.nlm.nih.gov/pubmed/27609756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw621
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars